Description
RADIOPHARMACEUTICALS - HINES VAH - SEPTEMBER 2010
First action · last action
2010-09-01 · 2010-09-30
Transactions
3
First transaction's obligation
$12,000
Base + all options value (sum of deltas)
$16,584
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2010-09-01+$12,000= $12,000
- Mod 12010-09-09+$12,000= $24,000
- Mod 22010-09-30-$7,416= $16,584
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2010-09-01 | +$12,000 | $12,000 | RADIOPHARMACEUTICALS - HINES VAH - SEPTEMBER 2010 |
| Mod 1· FUNDING ONLY ACTION | 2010-09-09 | +$12,000 | $24,000 | RADIOPHARMACEUTICALS - HINES VAH - SEPTEMBER 2010 |
| Mod 2· CLOSE OUT | 2010-09-30 | −$7,416 | $16,584 | RADIOPHARMACEUTICALS - HINES VAH - SEPTEMBER 2010 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI MF41LR58N9F7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA25012F0662 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $13,906 | FY2012 |
| VA25012F0576 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $8,857 | FY2012 |
| VA25012P0592 | 552-DAYTON · 6505 · DRUGS AND BIOLOGICALS | $2,194 | FY2012 |
| VA25012F0488 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $9,267 | FY2012 |
| VA25012J0461 | 757-COLUMBUS · 6505 · DRUGS AND BIOLOGICALS | $10,448 | FY2012 |
| VA25012F0482 | 552-DAYTON · 6505 · DRUGS AND BIOLOGICALS | $3,074 | FY2012 |
Other recipients under 6505 from 69D-NETWORK CONTRACT OFFICE 12 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA69D16F2903 | CSL BEHRING L.L.C. | 69D-NETWORK CONTRACT OFFICE 12 | $5,443 | FY2016 |
| VA69D16F2824 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $53,837 | FY2016 |
| VA69D16F2687 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $54,563 | FY2016 |
| VA69D16F2660 | SEQIRUS USA INC | 69D-NETWORK CONTRACT OFFICE 12 | $125,000 | FY2016 |
| VA69D16F2658 | SANOFI VACCINES US INC. | 69D-NETWORK CONTRACT OFFICE 12 | $141,675 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA69D578C00558_3600_-NONE-_-NONE- · retrieved 2026-09-26.